Clinical Trial Update: Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized study comparing CMF to Goserelin + Tamoxifen in premenopausal receptor-positive early-stage breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CMF (cyclophosphamide, methotrexate, and fluorouracil)
• Goserelin (Goserelin)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Early-stage Breast Cancer | Phase 3 | Status: COMPLETED